Premium
The Efficacy of a Single Intraperitoneal Injection of Flumequine in the Treatment of Systemic Vibriosis in Corkwing Wrasse Symphodus melops
Author(s) -
Samuelsen Ole Bent,
Husgard Susanna,
Torkildsen Lise,
Bergh Øivind
Publication year - 2000
Publication title -
journal of aquatic animal health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.507
H-Index - 52
eISSN - 1548-8667
pISSN - 0899-7659
DOI - 10.1577/1548-8667(2000)012<0324:teoasi>2.0.co;2
Subject(s) - wrasse , flumequine , intraperitoneal injection , biology , saline , fish <actinopterygii> , population , veterinary medicine , microbiology and biotechnology , fishery , medicine , antibiotics , pharmacology , ciprofloxacin , endocrinology , enrofloxacin , environmental health
In this investigation, the efficacy of a single intraperitoneal injection of flumequine in the treatment of systemic vibriosis in corkwing wrasse Symphodus melops was examined. In a population of corkwing wrasse that was experiencing daily mortality, the dominant bacterium cultivated from kidney samples of dead fish was tentatively classified as a species of Vibrio resembling V. splendidus. The infected fish were randomly divided into two groups, each of 60 individuals. Group 1 was treated with flumequine (25 mg/kg of fish) administered by a single intraperitoneal injection, whereas the fish from group 2 were injected with saline. The mortality was observed daily for 21 d. The cumulative mortality was significantly ( P < 0.005) higher in the control group (58%) compared with the medicated group (11%). Bacterial examination of kidneys from dead and surviving fish of both groups indicated the Vibrio to be quickly and effectively eliminated by the antibacterial agent.